{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:51:13Z","timestamp":1791168673834,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11565-8","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:05:43Z","timestamp":1777842343000},"page":"7365-7399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design, synthesis, in silico and in vitro anti-breast cancer evaluation of novel indole-isoxazole\/isoxazoline hybrids as ER\u03b1 inhibitors"],"prefix":"10.1007","volume":"30","author":[{"given":"Agnidipta","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Vishakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Midha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mayank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Baranwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhim","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Gangwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Jaitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"issue":"1","key":"11565_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-016-2777-z","volume":"420","author":"H Ananda","year":"2016","unstructured":"Ananda H, Kumar KSS, Hegde M, Rangappa KS (2016) Induction of apoptosis and downregulation of ER\u03b1 in DMBA-induced mammary gland tumors in Sprague-Dawley rats by synthetic 3, 5-disubstituted isoxazole derivatives. Mol Cell Biochem 420(1):141\u2013150. https:\/\/doi.org\/10.1007\/s11010-016-2777-z","journal-title":"Mol Cell Biochem"},{"key":"11565_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113511","volume":"221","author":"GC Arya","year":"2021","unstructured":"Arya GC, Kaur K, Jaitak V (2021) Isoxazole derivatives as anticancer agent: a review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 221:113511. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113511","journal-title":"Eur J Med Chem"},{"issue":"7","key":"11565_CR3","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.1021\/acsomega.2c07793","volume":"8","author":"O Bender","year":"2023","unstructured":"Bender O, Celik I, Dogan R, Atalay A, Shoman ME, Ali TF, Beshr EA, Mohamed M, Alaaeldin E, Shawky AM (2023) Vanillin-based indolin-2-one derivative bearing a pyridyl moiety as a promising anti-breast cancer agent via anti-estrogenic activity. ACS Omega 8(7):6968\u20136981. https:\/\/doi.org\/10.1021\/acsomega.2c07793","journal-title":"ACS Omega"},{"issue":"18","key":"11565_CR4","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1016\/j.bmcl.2017.08.033","volume":"27","author":"S Burra","year":"2017","unstructured":"Burra S, Voora V, Rao CP, Kumar PV, Kancha RK, Krupadanam GD (2017) Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines. Bioorg Med Chem Lett 27(18):4314\u20134318. https:\/\/doi.org\/10.1016\/j.bmcl.2017.08.033","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"11565_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011011","volume":"5","author":"M Dalvai","year":"2010","unstructured":"Dalvai M, Bystricky K (2010) Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and ER target gene expression. PLoS ONE 5(6):e11011","journal-title":"PLoS ONE"},{"issue":"29","key":"11565_CR6","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.2174\/0929867329666221006110528","volume":"30","author":"A Das","year":"2023","unstructured":"Das A, Lavanya KJ, Nandini KK, Jaitak V (2023) Effectiveness of selective estrogen receptor modulators in breast cancer therapy: an update. Curr Med Chem 30(29):3287\u20133314. https:\/\/doi.org\/10.2174\/0929867329666221006110528","journal-title":"Curr Med Chem"},{"key":"11565_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.857590","volume":"12","author":"J Datta","year":"2022","unstructured":"Datta J, Willingham N, Manouchehri JM, Schnell P, Sheth M, David JJ, Kassem M, Wilson TA, Radomska HS, Coss CC (2022) Activity of estrogen receptor \u03b2 agonists in therapy-resistant estrogen receptor-positive breast cancer. Front Oncol 12:857590. https:\/\/doi.org\/10.3389\/fonc.2022.857590","journal-title":"Front Oncol"},{"issue":"20","key":"11565_CR8","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1021\/acs.jmedchem.5b00984","volume":"58","author":"C De Savi","year":"2015","unstructured":"De Savi C, Bradbury RH, Rabow AA, Norman RA, de Almeida C, Andrews DM, Ballard P, Buttar D, Callis RJ, Currie GS (2015) Optimization of a novel binding motif to (E)-3-(3, 5-difluoro-4-((1 R, 3 R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2, 3, 4, 9-tetrahydro-1 H-pyrido [3, 4-b] indol-1-yl) phenyl) acrylic Acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist. J Med Chem 58(20):8128\u20138140. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00984","journal-title":"J Med Chem"},{"key":"11565_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.128140","volume":"1212","author":"M G\u00f6kalp","year":"2020","unstructured":"G\u00f6kalp M, Dede B, Tilki T, Atay \u00c7K (2020) Triazole based azo molecules as potential antibacterial agents: synthesis, characterization, DFT, ADME and molecular docking studies. J Mol Struct 1212:128140. https:\/\/doi.org\/10.1016\/j.molstruc.2020.128140","journal-title":"J Mol Struct"},{"issue":"1","key":"11565_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-021-00793-8","volume":"15","author":"M Hawash","year":"2021","unstructured":"Hawash M, Kahraman DC, Ergun SG, Cetin-Atalay R, Baytas SN (2021) Synthesis of novel indole-isoxazole hybrids and evaluation of their cytotoxic activities on hepatocellular carcinoma cell lines. BMC Chem 15(1):66. https:\/\/doi.org\/10.1186\/s13065-021-00793-8","journal-title":"BMC Chem"},{"issue":"7","key":"11565_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1210\/me.2004-0050","volume":"18","author":"A Hillisch","year":"2004","unstructured":"Hillisch A, Peters O, Kosemund D, M\u00fcller G, Walter A, Schneider B, Reddersen G, Elger W, Fritzemeier K-H (2004) Dissecting physiological roles of estrogen receptor \u03b1 and \u03b2 with potent selective ligands from structure-based design. Mol Endocrinol 18(7):1599\u20131609. https:\/\/doi.org\/10.1210\/me.2004-0050","journal-title":"Mol Endocrinol"},{"key":"11565_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1586191","volume":"16","author":"Z Hong","year":"2025","unstructured":"Hong Z, Mo T, Chen J, Li X (2025) Progress of estrogen receptor and spliceosome in endometrial carcinoma. Front Endocrinol 16:1586191. https:\/\/doi.org\/10.3389\/fendo.2025.1586191","journal-title":"Front Endocrinol"},{"issue":"3","key":"11565_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41416-023-02158-5","volume":"128","author":"A Howell","year":"2023","unstructured":"Howell A, Howell SJ (2023) Tamoxifen evolution. Br J Cancer 128(3):421\u2013425. https:\/\/doi.org\/10.1038\/s41416-023-02158-5","journal-title":"Br J Cancer"},{"issue":"1","key":"11565_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71729-0","volume":"14","author":"A Iraji","year":"2024","unstructured":"Iraji A, Nikfar P, Nazari Montazer M, Karimi M, Edraki N, Saeedi M, Mirfazli SS (2024) Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer\u2019s agents. Sci Rep 14(1):21115. https:\/\/doi.org\/10.1038\/s41598-024-71729-0","journal-title":"Sci Rep"},{"issue":"1","key":"11565_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.7908","volume":"39","author":"KM Ismail","year":"2025","unstructured":"Ismail KM, Hassan SS, Hanna DH (2025) Palladium-imidazole nanoparticles\u2019 cytotoxic effects on colon cancer cells: induction of cell cycle arrest and apoptosis mediated via mitochondria. Appl Organomet Chem 39(1):e7908. https:\/\/doi.org\/10.1002\/aoc.7908","journal-title":"Appl Organomet Chem"},{"issue":"11","key":"11565_CR16","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1016\/j.bmcl.2005.03.111","volume":"15","author":"Q Ji","year":"2005","unstructured":"Ji Q, Gao J, Wang J, Yang C, Hui X, Yan X, Wu X, Xie Y, Wang M-W (2005) Benzothieno [3, 2-b] indole derivatives as potent selective estrogen receptor modulators. Bioorg Med Chem Lett 15(11):2891\u20132893. https:\/\/doi.org\/10.1016\/j.bmcl.2005.03.111","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"11565_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1039\/D3MD00730H","volume":"15","author":"K Kaur","year":"2024","unstructured":"Kaur K, Verma H, Gangwar P, Dhiman M, Jaitak V (2024) Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents. RSC Med Chem 15(4):1329\u20131347. https:\/\/doi.org\/10.1039\/D3MD00730H","journal-title":"RSC Med Chem"},{"key":"11565_CR18","doi-asserted-by":"publisher","DOI":"10.1039\/D5MD00297D","author":"K Kaur","year":"2025","unstructured":"Kaur K, Verma H, Gangwar P, Dhiman M, Jaitak V (2025) Design, synthesis and biological evaluation of novel bis (indolyl)-tetrazine derivatives as anti-breast cancer agents. RSC Med Chem. https:\/\/doi.org\/10.1039\/D5MD00297D","journal-title":"RSC Med Chem"},{"key":"11565_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107341","volume":"147","author":"K Kaur","year":"2024","unstructured":"Kaur K, Verma H, Gangwar P, Jangid K, Dhiman M, Kumar V, Jaitak V (2024) Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha. Bioorg Chem 147:107341. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107341","journal-title":"Bioorg Chem"},{"issue":"3","key":"11565_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrd3373","volume":"10","author":"O Kepp","year":"2011","unstructured":"Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G (2011) Cell death assays for drug discovery. Nat Rev Drug Discov 10(3):221\u2013237","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"11565_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081909","volume":"25","author":"N Kerru","year":"2020","unstructured":"Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB (2020) A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules 25(8):1909","journal-title":"Molecules"},{"key":"11565_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I, Fidler-Benaoudia MM (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"11565_CR23","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S289008","author":"X Liu","year":"2021","unstructured":"Liu X, Shan K, Shao X, Shi X, He Y, Liu Z, Jacob JA, Deng L (2021) Nanotoxic effects of silver nanoparticles on normal HEK-293 cells in comparison to cancerous HeLa cell line. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S289008","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"11565_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cbi.2010.05.015","volume":"186","author":"HH Nguyen","year":"2010","unstructured":"Nguyen HH, Lavrenov SN, Sundar SN, Nguyen DH, Tseng M, Marconett CN, Kung J, Staub RE, Preobrazhenskaya MN, Bjeldanes LF (2010) 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells. Chem Biol Interact 186(3):255\u2013266. https:\/\/doi.org\/10.1016\/j.cbi.2010.05.015","journal-title":"Chem Biol Interact"},{"key":"11565_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","volume":"186","author":"HK Patel","year":"2018","unstructured":"Patel HK, Bihani T (2018) Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Pharmacol Ther 186:1\u201324. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.12.012","journal-title":"Pharmacol Ther"},{"issue":"1","key":"11565_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","volume":"3","author":"JC Reed","year":"2003","unstructured":"Reed JC (2003) Apoptosis-targeted therapies for cancer. Cancer Cell 3(1):17\u201322","journal-title":"Cancer Cell"},{"issue":"11","key":"11565_CR27","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1007\/s11696-021-01775-9","volume":"75","author":"FC Rodrigues","year":"2021","unstructured":"Rodrigues FC, Kumar NA, Hari G, Pai K, Thakur G (2021) The inhibitory potency of isoxazole-curcumin analogue for the management of breast cancer: a comparative in vitro and molecular modeling investigation. Chem Pap 75(11):5995\u20136008. https:\/\/doi.org\/10.1007\/s11696-021-01775-9","journal-title":"Chem Pap"},{"key":"11565_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.crstbi.2024.100124","volume":"7","author":"B Saha","year":"2024","unstructured":"Saha B, Das A, Jangid K, Kumar A, Kumar V, Jaitak V (2024) Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer\u2019s disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD simulation study. Curr Res Struct Biol 7:100124","journal-title":"Curr Res Struct Biol"},{"issue":"1","key":"11565_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13065-018-0472-8","volume":"12","author":"D Sharma","year":"2018","unstructured":"Sharma D, Kumar S, Narasimhan B (2018) Estrogen alpha receptor antagonists for the treatment of breast cancer: a review. Chem Cent J 12(1):107\u2013107. https:\/\/doi.org\/10.1186\/s13065-018-0472-8","journal-title":"Chem Cent J"},{"issue":"03","key":"11565_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-0035-1555804","volume":"66","author":"K Sharma","year":"2016","unstructured":"Sharma K, Pachauri S, Khandelwal K, Ahmad H, Arya A, Biala P, Agrawal S, Pandey R, Srivastava A, Srivastav A (2016) Anticancer effects of extracts from the fruit of Morinda citrifolia (Noni) in breast cancer cell lines. Drug Res 66(03):141\u2013147. https:\/\/doi.org\/10.1055\/s-0035-1555804","journal-title":"Drug Res"},{"issue":"1","key":"11565_CR31","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"11565_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2022.100433","volume":"99","author":"MB Singh","year":"2022","unstructured":"Singh MB, Jain P, Tomar J, Kumar V, Bahadur I, Arya DK, Singh P (2022) An in silico investigation for acyclovir and its derivatives to fight the COVID-19: molecular docking, DFT calculations, ADME and td-molecular dynamics simulations. J Indian Chem Soc 99(5):100433. https:\/\/doi.org\/10.1016\/j.jics.2022.100433","journal-title":"J Indian Chem Soc"},{"key":"11565_CR33","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejmech.2018.01.051","volume":"146","author":"R Singla","year":"2018","unstructured":"Singla R, Gupta KB, Upadhyay S, Dhiman M, Jaitak V (2018) Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-\u03b1). Eur J Med Chem 146:206\u2013219. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.051","journal-title":"Eur J Med Chem"},{"issue":"1","key":"11565_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bmc.2017.11.040","volume":"26","author":"R Singla","year":"2018","unstructured":"Singla R, Gupta KB, Upadhyay S, Dhiman M, Jaitak V (2018) Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators. Bioorg Med Chem 26(1):266\u2013277. https:\/\/doi.org\/10.1016\/j.bmc.2017.11.040","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"11565_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/1573409913666170406144642","volume":"13","author":"R Singla","year":"2017","unstructured":"Singla R, Jaitak V (2017) Multitargeted molecular docking study of natural-derived alkaloids on breast cancer pathway components. Curr Comput-Aided Drug Des 13(4):294\u2013302. https:\/\/doi.org\/10.2174\/1573409913666170406144642","journal-title":"Curr Comput-Aided Drug Des"},{"key":"11565_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/117822341000400004","volume":"4","author":"K Subik","year":"2010","unstructured":"Subik K, Lee J-F, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung M-C, Bonfiglio T, Hicks DG (2010) The expression patterns of ER, PR, HER2, CK5\/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer Auckl 4:117822341000400004. https:\/\/doi.org\/10.1177\/117822341000400004","journal-title":"Breast Cancer Auckl"},{"issue":"16","key":"11565_CR37","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZ, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119(16):9478\u20139508","journal-title":"Chem Rev"},{"issue":"22","key":"11565_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells14221832","volume":"14","author":"K Wang","year":"2025","unstructured":"Wang K, Li Z-L, Huang L-Y, Yao C-J, Crawford DR, Wang C-Y, Mo J-K, Shih Y-J, Lin H-Y, Whang-Peng J (2025) Integrin \u03b1v\u03b23 as a non-genomic estrogen receptor in breast cancer for signaling pathways and crosstalk. Cells 14(22):1832","journal-title":"Cells"},{"issue":"10","key":"11565_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jnutbio.2005.10.012","volume":"17","author":"TT Wang","year":"2006","unstructured":"Wang TT, Milner MJ, Milner JA, Kim YS (2006) Estrogen receptor \u03b1 as a target for indole-3-carbinol. J Nutr Biochem 17(10):659\u2013664. https:\/\/doi.org\/10.1016\/j.jnutbio.2005.10.012","journal-title":"J Nutr Biochem"},{"key":"11565_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.fct.2014.01.040","volume":"66","author":"Y-S Won","year":"2014","unstructured":"Won Y-S, Lee J-H, Kwon S-J, Kim J-Y, Park K-H, Lee M-K, Seo K-I (2014) \u03b1-Mangostin-induced apoptosis is mediated by estrogen receptor \u03b1 in human breast cancer cells. Food Chem Toxicol 66:158\u2013165. https:\/\/doi.org\/10.1016\/j.fct.2014.01.040","journal-title":"Food Chem Toxicol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11565-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11565-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:03:25Z","timestamp":1791165805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11565-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11565"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11565-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}